
Ketamine is presented as a novel therapeutic compound, as it induces dissociative states and separateness from grief. The trial also reveals positive changes to neural circuity that makes emotion easier to process.

"The speaker discusses ketamine as a novel therapeutic compound for treating depression, noting its use in psychiatric clinics to create dissociative states. Listeners might be interested if they are looking for alternative treatments for severe depression."




